FDA-Inspected Site

Noven Pharmaceuticals, Inc.

13 FDA inspections are on record for Noven Pharmaceuticals, Inc. in Miami, United States.

Clean· No action indicated

Miami, United States · Last updated July 10, 2026

Overview

  • 13 FDA inspections are on record.
  • 5 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-02-13.

At a glance

Inspections

13

Form 483s

5

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Feb 2026 – 13 Feb 2026Human DrugsClean
1 Nov 2021 – 17 Nov 2021Human Drugs483View 483 →
18 Jan 2018 – 26 Jan 2018Human Drugs483On file
22 Jun 2015 – 10 Jul 2015Human DrugsWLView 483 →
24 Sep 2012Not recordedClean
4 Jun 2012Not recordedClean
6 May 2010Not recorded483View 483 →
6 Feb 2009Not recorded483View 483 →
2 Jul 2007Not recordedWL
17 Nov 2003Not recordedClean
7 Jul 2003Not recordedClean
29 Jul 2002Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

17 Nov 2021
21 CFR 211.192

Extent of discrepancy, failure investigations

Cited by Jennifer Lalama, Kayla V Sprague, Lillian M Colon-Mcknight

17 Nov 2021
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Jennifer Lalama, Kayla V Sprague, Lillian M Colon-Mcknight

17 Nov 2021
21 CFR 211.46(b)

Equipment for Environmental Control

Cited by Jennifer Lalama, Kayla V Sprague, Lillian M Colon-Mcknight

17 Nov 2021
21 CFR 211.56(b)

Written sanitation procedures not followed

Cited by Jennifer Lalama, Kayla V Sprague, Lillian M Colon-Mcknight

10 Jul 2015
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Jessica L Pressley, Jennifer Lalama, Ileana Barreto-Pettit, Cheryl A Clausen, Richard A Lyght, Caroline Strasinger, Sarah Ibrahim

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations6x
21 CFR 211.100(a)Cited across public-safe Form 483 observations4x
21 CFR 211.110(a)Cited across public-safe Form 483 observations4x
21 CFR 211.111Cited across public-safe Form 483 observations2x
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations2x
21 CFR 211.166(a)Cited across public-safe Form 483 observations2x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations2x
21 CFR 314.80(c)(1)(ii)Cited across public-safe Form 483 observations2x
21 CFR 314.81(b)(1)(ii)Cited across public-safe Form 483 observations2x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.46(b)Cited across public-safe Form 483 observations1x
21 CFR 211.56(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Noven Pharmaceuticals, Inc.'s 5 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat